Lansoprazole Teva Sante

Lansoprazole, the active ingredient in Lansoprazole Teva Sante, is a proton pump inhibitor presented as an oral dosage form for systemic use. It reduces gastric acid production and is used to manage conditions such as gastro‑esophageal reflux disease, peptic ulcer disease, and in Helicobacter pylori eradication regimens.

GNH USA supplies Lansoprazole Teva Sante as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and research institutions across multiple regions worldwide, with consistent quality assurance and regulatory compliance, and on‑time delivery.

Lansoprazole is a proton pump inhibitor used to treat acid‑related gastrointestinal disorders. - Gastro‑esophageal reflux disease (GERD): reduces acid exposure, relieving heartburn and facilitating healing of esophageal irritation. - Peptic ulcer disease: suppresses gastric acid to allow ulcer healing and lower risk of recurrence. - Helicobacter pylori eradication regimens: improves the effectiveness of antibiotic therapy by maintaining a less acidic gastric environment. - Erosive esophagitis: promotes mucosal healing by reducing acid‑mediated injury. - Zollinger‑Ellison syndrome: provides high‑dose acid suppression in hypersecretory conditions.

Common side effects are generally mild and transient.

Common Side Effects: - Headache - Diarrhea - Abdominal pain - Nausea

Serious or Rare Side Effects: - Clostridioides difficile infection - Severe allergic reaction (anaphylaxis) - Elevated liver enzymes

Before initiating therapy, consider the following precautions. - Renal function assessment: adjust use in severe renal impairment. - Hepatic impairment: monitor liver function tests. - Concomitant medications: review drugs that require gastric acidity for absorption. - Infection risk: be alert for signs of gastrointestinal infections. - Osteoporosis risk: prolonged use may increase fracture risk. - Store at room temperature: keep in the original pack, protect from moisture.

Lansoprazole may interact with several medicines; monitor accordingly.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Atazanavir: decreased absorption and efficacy. - High‑dose methotrexate: increased toxicity risk.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR. - Digoxin: potential rise in serum levels. - Diazepam: may increase plasma concentration.